NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.38%430.140.0%$5769.95m
BNTXBioNTech SE -5.53%333.480.0%$994.80m
NVAXNovavax, Inc. -3.55%248.1679.4%$950.95m
SNSSSunesis Pharmaceuticals, Inc. -0.46%8.650.7%$604.67m
AMGNAmgen, Inc. -0.67%213.611.4%$550.92m
GILDGilead Sciences, Inc. -0.70%71.191.0%$455.28m
REGNRegeneron Pharmaceuticals, Inc. -1.18%638.902.7%$418.56m
TECHBio-Techne Corp. 0.37%538.884.5%$356.85m
ILMNIllumina, Inc. -0.09%432.823.5%$356.73m
BIIBBiogen, Inc. -0.51%291.711.7%$309.48m
VRTXVertex Pharmaceuticals, Inc. -0.80%183.611.9%$245.25m
ISEEIVERIC bio, Inc. 0.86%16.370.0%$193.25m
DVAXDynavax Technologies Corp. 1.17%19.835.7%$156.65m
LIFEaTyr Pharma, Inc. -17.87%10.252.1%$156.36m
BGNEBeiGene Ltd. -1.53%379.521.3%$144.32m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.